MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

Phase 3
Recruiting
Conditions
Follicular Lymphoma (FL)
Interventions
First Posted Date
2023-10-24
Last Posted Date
2025-01-10
Lead Sponsor
Regeneron Pharmaceuticals
Target Recruit Count
733
Registration Number
NCT06097364
Locations
🇬🇧

The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, London, United Kingdom

🇺🇸

Investigative Clinical Research of Indiana, Noblesville, Indiana, United States

🇺🇸

University of Kentucky, Lexington, Kentucky, United States

and more 70 locations
© Copyright 2025. All Rights Reserved by MedPath